Your session is about to expire
← Back to Search
Antiseptic
Aqueous vs Alcohol Chlorhexidine for Cesarean Section Infection
Phase 4
Waitlist Available
Led By Yaneve Fonge, MD
Research Sponsored by Yaneve Fonge
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 30 days post cesarean
Awards & highlights
No Placebo-Only Group
Pivotal Trial
Drug Has Already Been Approved
Summary
This trial is testing two different skin cleaning solutions to see which one better prevents infections after a cesarean section. The study involves patients who are having a cesarean delivery. The cleaning solutions work by killing germs on the skin before surgery to reduce the risk of infection. One solution has been compared to another in various studies for its effectiveness in reducing surgical site infections.
Who is the study for?
This trial is for women who are scheduled to have a cesarean delivery at Magee Women's Hospital. It aims to find out which skin cleaning method is better at preventing infections after surgery.
What is being tested?
The study compares two ways of cleaning the skin before C-sections: one uses a water-based Chlorhexidine solution, and the other uses Chlorhexidine with alcohol. The goal is to see which one lowers infection risk more effectively.
What are the potential side effects?
Possible side effects from using Chlorhexidine may include skin irritation or allergic reactions, but these are generally mild. Since it's applied externally, systemic side effects are rare.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ within 30 days post cesarean
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 30 days post cesarean
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Number of Participants with Surgical site Infection
Secondary study objectives
Antibiotic regimens (medication names) used to treat infection
Cost Savings
Number of Participants with sepsis
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Drug Has Already Been Approved
The FDA has already approved this drug, and is just seeking more data.
Trial Design
2Treatment groups
Experimental Treatment
Group I: 4% chlorhexidine gluconate (Hibiclens)Experimental Treatment1 Intervention
Including cases undergoing elective \& nonelective caesarean section. Patients will be scrubbed preoperative with an applicator that contain 4% chlorohexidine aqueous solution (3 consecutive applications) liberally over 2 minutes followed by drying with sterile towel. The area scrubbed will be the same as the chloraprep group.
Group II: 2% Chlorhexidine gluconate with 70% alcohol (ChloraPrep)Experimental Treatment1 Intervention
Including cases undergoing elective \&non elective caesarean section. Patients will be prepared similarly using the appropriate number of 26mL Chloraprep sticks for their body surface area. The lever will be pinched to activate the ampoule and release the antiseptic. The solution will be given time to partially load in the sponge. The sponge will be pressed against the skin area where the incision is intended moving back and forth for 30 sec , then working up towards the upper edge of the surgical field and then working from below the incision sight to the upper thighs. The antiseptic will be given time to dry (3 min)
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Chlorhexidine is an antimicrobial agent that disrupts microbial cell membranes, leading to cell death. This mechanism is crucial for preventing Surgical Site Infections (SSIs) as it effectively reduces the microbial load on the skin, minimizing the risk of infection during and after surgery.
The use of Chlorhexidine in preoperative skin preparation has been shown to lower the incidence of SSIs, which is vital for improving patient outcomes and reducing healthcare costs associated with postoperative infections.
Find a Location
Who is running the clinical trial?
Yaneve FongeLead Sponsor
University of PittsburghLead Sponsor
1,789 Previous Clinical Trials
16,358,153 Total Patients Enrolled
Yaneve Fonge, MDPrincipal InvestigatorUniversity of Pittsburgh
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: 2% Chlorhexidine gluconate with 70% alcohol (ChloraPrep)
- Group 2: 4% chlorhexidine gluconate (Hibiclens)
Awards:
This trial has 3 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger